生体腎移植術後に可逆性後白質脳症症候群Posterior reversible encephalopathy syndrome(PRES)を来たした1例

HANDLE Web Site オープンアクセス

書誌事項

タイトル別名
  • Posterior Reversible Encephalopathy Syndrome (PRES) after Kidney Transplantation : A Case Report
  • セイタイジンイショク ジュツゴ ニ カギャクセイ ゴ ハクシツ ノウショウ ショウコウグン Posterior reversible encephalopathy syndrome(PRES)オ キタ シタ 1レイ

この論文をさがす

抄録

A 60-year-old woman with chronic renal failure due to a polycystic kidney underwent living kidney transplantation. Initial immunosuppressive therapy consisted of tacrolimus (TAC), mycophenolate mofetil (MMF), prednisolone, and basiliximab. Furthermore, rituximab was administered, and double filtration plasmapheresis and plasma exchange were utilized because of ABO-incompatible transplantation, while intravenous immune serum globulin (IVIG) was given because donor specific antibody was positive. Four days after the renal transplantation, the patient developed visual abnormalities, a headache, and paralysis. Then, he became unconscious. Magnetic resonance imaging of the brain demonstrated bilateral posterior vasogenic edema. Our diagnosis was posterior reversible encephalopathy syndrome due to TAC neurotoxicity. After converting TAC to reduced cyclosporine and everolimus, the symptoms rapidly disappeared.

収録刊行物

  • 泌尿器科紀要

    泌尿器科紀要 60 (8), 387-392, 2014-08

    泌尿器科紀要刊行会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ